Medical, Legal, and Regulatory (MLR) review is one of the most critical, and often time-consuming, steps in pharmaceutical content production.
As the volume of omnichannel promotional materials continues to grow, many pharma organizations are exploring how artificial intelligence (AI) can support faster, more efficient MLR review processes.
AI is not replacing MLR expertise.
Instead, it is helping teams reduce manual tasks, identify risks earlier, and accelerate compliant content approvals.